Alopecia or Hair Loss affects both men and women, although usually in different ways. The most common form of hair...
Dermatology, Mental Health Research / 26.07.2024
The Psychological Benefits of Effective Hair Loss Treatments
Hair loss can have profound psychological effects, impacting self-esteem and overall well-being. However, advancements in hair loss treatments, such as Minoxidil, offer hope by not only addressing physical symptoms but also improving mental health outcomes. Understanding the psychological benefits of these treatments is crucial for individuals seeking to regain confidence and emotional balance.
Image source[/caption]
Minoxidil, a topical medication approved by the FDA for hair loss treatment, stimulates hair follicles' growth phase and increases hair density. It promotes blood flow to the scalp, revitalizing dormant follicles and encouraging new hair growth. Minoxidil hair treatment offers a proactive approach that not only addresses thinning hair but also restores confidence in one's appearance.
Addressing the Emotional Impact of Hair Loss
Hair loss is more than a cosmetic concern; it can significantly affect mental health. Many individuals experience feelings of embarrassment, anxiety, and reduced self-confidence due to changes in their appearance. Effective hair loss treatments play a pivotal role in alleviating these psychological burdens, fostering a positive outlook and enhancing quality of life.How Minoxidil Works
[caption id="attachment_62607" align="alignleft" width="200"] Image source[/caption]
Minoxidil, a topical medication approved by the FDA for hair loss treatment, stimulates hair follicles' growth phase and increases hair density. It promotes blood flow to the scalp, revitalizing dormant follicles and encouraging new hair growth. Minoxidil hair treatment offers a proactive approach that not only addresses thinning hair but also restores confidence in one's appearance.
Have you ever wondered about the best treatment options for HAE patients? How do you
decide which treatment is right? Understanding the trade-offs is essential. This article explores
the benefits and risks of various HAE treatments. Let's delve into the specifics.
What is HAE?
Hereditary Angioedema (HAE) is a rare genetic disorder. It causes sudden swelling in various parts of the body. These swelling episodes can be painful and dangerous. Knowing the details of this condition is crucial. It helps in making informed treatment decisions. Effective management is vital for improving patient outcomes.Types of HAE Treatments
HAE treatments can be categorized. They include acute treatments and prophylactic treatments. Acute treatments are used during an attack. Prophylactic treatments are used to prevent attacks. Each treatment type has its own set of benefits and risks. The choice of treatment depends on individual patient needs. Understanding these treatments helps in better patient care.
Dermatology / 05.07.2024
What Is BioRePeel and How Does It Work?
It is recommended to avoid direct sun exposure for the first several weeks after the procedure to protect his or...
Dermatology / 03.07.2024
Home Remedies To Help Manage Eczema
Eczema, also known as atopic dermatitis, is a chronic skin condition characterized by dry, itchy, and inflamed skin. While there are various treatments available, many people turn to home remedies to manage their symptoms. In this article, several natural remedies for eczema are explored, some remedies that should be avoided are discussed and tips for treating eczema in babies and children are identified.
Natural Remedies for Eczema
Home natural remedy for eczema may provide significant relief and improve the condition of the skin. Colloidal oatmeal, for instance, is renowned for its soothing properties, helping to alleviate itching and irritation. Simply adding it to a warm bath can create a calming treatment. Another effective remedy is coconut oil, which hydrates the skin and may contain antibacterial properties that help prevent infection. Applying it directly to affected areas twice daily may make a noticeable difference. Additionally, sunflower seed oil may strengthen the skin barrier and reduce inflammation when used as a moisturizer. Bleach baths, although sounding harsh, may reduce bacteria on the skin and are beneficial when used sparingly. Lastly, using a cool compress can provide immediate relief from severe itching and inflammation. These natural remedies are gentle yet effective ways to manage eczema symptoms and enhance overall skin health. Contact a healthcare professional before using any natural remedy. They can help ensure the remedy fits safely within a treatment plan. Remember allergic reactions can occur or develop to any product so be sure to monitor your skin for any new or unexpected reactions. Test any new product on a small area before applying to larger areas.
Want to achieve that radiant, healthy glow? You’re in the right place. In this guide, we’re sharing five essential dermatology tips, straight from the experts, to help you get the skin of your dreams. From the best skincare routines to insider secrets on keeping your skin youthful and vibrant, we’ve got you covered.
I can’t stress this enough - sunscreen is a must! Here’s why:
1. Sunscreen: Your Skin’s Best Friend
I can’t stress this enough - sunscreen is a must! Here’s why:
- Protects against harmful UV rays
- Prevents premature aging
- Reduces risk of skin cancer
For stubborn hyperpigmentation, professional treatments may be necessary. Chemical peels, laser therapy and microdermabrasion can significantly improve skin tone and...
Author Interviews, Dermatology, JAMA, Salt-Sodium / 12.06.2024
UCSF Study Finds Salt Intake May Be Associated with Eczema Severity
MedicalResearch.com Interview with:
[caption id="attachment_61942" align="alignleft" width="200"] Dr. Abuabar[/caption]
Katrina Abuabara, MD, MA, MSCE
Associate Professor of Dermatology, UCSF
Associate Adjunct Professor of Epidemiology
UC Berkeley School of Public Health
MedicalResearch.com: What is the background for this study?
Response: Eczema (also known as atopic dermatitis) has become increasingly common over recent decades, especially in industrialized countries, suggesting that environmental or lifestyle factors like diet could impact rates of disease. It is well established that sodium, consumed primarily in the form of salt, increases the risk of hypertension and heart disease through pro-inflammatory mechanisms. The role of sodium on other chronic inflammatory conditions like eczema has been less well-studied.
Dr. Abuabar[/caption]
Katrina Abuabara, MD, MA, MSCE
Associate Professor of Dermatology, UCSF
Associate Adjunct Professor of Epidemiology
UC Berkeley School of Public Health
MedicalResearch.com: What is the background for this study?
Response: Eczema (also known as atopic dermatitis) has become increasingly common over recent decades, especially in industrialized countries, suggesting that environmental or lifestyle factors like diet could impact rates of disease. It is well established that sodium, consumed primarily in the form of salt, increases the risk of hypertension and heart disease through pro-inflammatory mechanisms. The role of sodium on other chronic inflammatory conditions like eczema has been less well-studied.
Author Interviews, Dermatology, Melanoma, Race/Ethnic Diversity / 24.05.2024
Weill Cornell Dermatologist Discusses Skin Cancer Prevention and Detection
MedicalResearch.com Interview with:
[caption id="attachment_61776" align="alignleft" width="125"] Dr. Alexis[/caption]
Andrew F. Alexis, MD, MPH
Vice-Chair for Diversity and Inclusion
Department of Dermatology
Dermatologist
Center for Diverse Skin Complexions
Weill Cornell Medicine – NY
MedicalResearch.com: What are the main types of skin cancer? Is the incidence changing?
Response: The 3 main types of skin cancer are melanoma, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Skin cancer is the most common cancer in the United States1 and 1 in 5 Americans will develop skin cancer in their lifetime. (2)
The overall incidence has changed as follows:
• Melanoma: Rates doubled over past 30 years from 1982 to 2011.3 It differs by age group.
o Adolescents and adults age 30 and younger: incidence rate is declining
o Older age groups (e.g. 80 and older): incidence rate is increasing
• Squamous Cell Cancer:
o Incidence increased 263% between 1976-1984 and 2000-20104
• Basal Cell Cancer:
o Incidence increased 145% between 1976-1984 and 2000-20104
Dr. Alexis[/caption]
Andrew F. Alexis, MD, MPH
Vice-Chair for Diversity and Inclusion
Department of Dermatology
Dermatologist
Center for Diverse Skin Complexions
Weill Cornell Medicine – NY
MedicalResearch.com: What are the main types of skin cancer? Is the incidence changing?
Response: The 3 main types of skin cancer are melanoma, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Skin cancer is the most common cancer in the United States1 and 1 in 5 Americans will develop skin cancer in their lifetime. (2)
The overall incidence has changed as follows:
• Melanoma: Rates doubled over past 30 years from 1982 to 2011.3 It differs by age group.
o Adolescents and adults age 30 and younger: incidence rate is declining
o Older age groups (e.g. 80 and older): incidence rate is increasing
• Squamous Cell Cancer:
o Incidence increased 263% between 1976-1984 and 2000-20104
• Basal Cell Cancer:
o Incidence increased 145% between 1976-1984 and 2000-20104
Our skin is subject to a multitude of internal and external influences that can affect its thickness and texture over time. Factors such as aging, environmental aggressors, lifestyle choices, and genetics can contribute to the gradual thinning and deterioration of skin quality. However, the good news is that there are various approaches to address these concerns and promote the restoration of skin thickness and texture.
In this article, we'll explore a few crucial factors that, according to research, play pivotal roles in this rejuvenation process.
According to the National Institutes of Health, at the core of skin thickness and texture restoration lies the process of cell proliferation and migration. The epidermis, the outermost layer of the skin, constantly undergoes renewal through a process known as epidermal turnover.
Stem cells within the basal layer of the epidermis divide and differentiate into keratinocytes. These gradually migrate upward to the skin's surface, replacing old, damaged cells.
According to Beyond CellCare, stem cell therapy differs from traditional treatments, which only target the symptoms of skin aging. By fostering cellular repair and renewal, it targets the fundamental mechanisms of aging.
Furthermore, certain skincare ingredients and treatments, such as chemical exfoliants and professional procedures like microdermabrasion and chemical peels, can accelerate cell turnover.
You’ll also find the use of exosome injection and similar therapy methods involving exosomes becoming popular in this regard. Exosomes facilitate skin cell proliferation and migration by transferring growth factors and signaling molecules.
(Please note that exosomes are currently not approved by the Food and Drug Administration (FDA) to treat or diagnose any disease).
The Proliferation and Migration of Skin Cells
According to the National Institutes of Health, at the core of skin thickness and texture restoration lies the process of cell proliferation and migration. The epidermis, the outermost layer of the skin, constantly undergoes renewal through a process known as epidermal turnover.
Stem cells within the basal layer of the epidermis divide and differentiate into keratinocytes. These gradually migrate upward to the skin's surface, replacing old, damaged cells.
According to Beyond CellCare, stem cell therapy differs from traditional treatments, which only target the symptoms of skin aging. By fostering cellular repair and renewal, it targets the fundamental mechanisms of aging.
Furthermore, certain skincare ingredients and treatments, such as chemical exfoliants and professional procedures like microdermabrasion and chemical peels, can accelerate cell turnover.
You’ll also find the use of exosome injection and similar therapy methods involving exosomes becoming popular in this regard. Exosomes facilitate skin cell proliferation and migration by transferring growth factors and signaling molecules.
(Please note that exosomes are currently not approved by the Food and Drug Administration (FDA) to treat or diagnose any disease).
Key Takeaways:
Laser hair removal is a long-lasting alternative to traditional hair removal methods for unwanted facial hair in both men and women. Laser treatments disrupt the normal growth cycle of hair follicles by utilizing highly concentrated beams of light designed to be absorbed by the pigment within the hair shafts. This state-of-the-art technique has quickly found favor in metropolises like Chicago, where grooming and self-care are highly prioritized. Laser facial hair removal in Chicago is primarily sought for its ability to facilitate a seamless, hair-free complexion, symbolic of the city's cosmopolitan lifestyle.
- Understanding the groundbreaking science behind laser facial hair removal and its multifaceted benefits.
- Key steps to consider in preparation for a laser hair removal session to ensure safety and effectiveness.
- Essential post-treatment care strategies to enhance results and maintain skin health after the procedure.
- The role of continuous technological advancements in improving laser hair removal treatments.
Laser hair removal is a long-lasting alternative to traditional hair removal methods for unwanted facial hair in both men and women. Laser treatments disrupt the normal growth cycle of hair follicles by utilizing highly concentrated beams of light designed to be absorbed by the pigment within the hair shafts. This state-of-the-art technique has quickly found favor in metropolises like Chicago, where grooming and self-care are highly prioritized. Laser facial hair removal in Chicago is primarily sought for its ability to facilitate a seamless, hair-free complexion, symbolic of the city's cosmopolitan lifestyle.
Author Interviews, Dermatology, Genetic Research, Nature, Rheumatology / 28.03.2024
Gene Mutation Discovered That May Lead Some Psoriasis Patients to Develop Arthritis
MedicalResearch.com Interview with:
[caption id="attachment_61503" align="alignleft" width="150"] Dr. Cardinez[/caption]
Chelisa Cardinez PhD
Postdoctoral Researcher
The Burr Laboratory- Cancer Immunology and Epigenetics
Genome Sciences and Cancer Division
The John Curtin School of Medical Research
The Australian National University
Canberra, Australia
MedicalResearch.com: What is the background for this study?
Response: Psoriasis is a skin inflammatory disease that affects approximately 2-3% of the population.
Previous research had identified that the cytokine IL-17 drives the development of this disease. However, key questions that remained unknown about psoriasis included where did the IL-17 come from, and why do some patients with psoriasis also go on to develop systemic inflammatory conditions such as arthritis. Our research aimed to address these questions using a gain of function (GoF) mouse model that carried a genetic variant in a gene called IKBKB.
Dr. Cardinez[/caption]
Chelisa Cardinez PhD
Postdoctoral Researcher
The Burr Laboratory- Cancer Immunology and Epigenetics
Genome Sciences and Cancer Division
The John Curtin School of Medical Research
The Australian National University
Canberra, Australia
MedicalResearch.com: What is the background for this study?
Response: Psoriasis is a skin inflammatory disease that affects approximately 2-3% of the population.
Previous research had identified that the cytokine IL-17 drives the development of this disease. However, key questions that remained unknown about psoriasis included where did the IL-17 come from, and why do some patients with psoriasis also go on to develop systemic inflammatory conditions such as arthritis. Our research aimed to address these questions using a gain of function (GoF) mouse model that carried a genetic variant in a gene called IKBKB.
Author Interviews, Dermatology, Kidney Stones, NEJM / 28.03.2024
NEJM: Some Hair Straightening Products May Cause Kidney Injury
[caption id="attachment_61496" align="alignleft" width="125"] Dr. Thomas Robert[/caption]
MedicalResearch.com Interview with:
Thomas Robert, MD, AIX
Associate Professor of Nephrology
APHM (Assistance Publique - Hopitaux de Marseille)
Marseille, Provence-Alpes-Côte d'Azur, France
[caption id="attachment_61498" align="alignleft" width="132"] Dr. Letavernier[/caption]
Prof. Emmanuel Letavernier, MD PhD
Nephrologist at Tenon Hospital
Paris, France
MedicalResearch.com: What is the background for this study?
Response: Our work was prompted by emerging concerns surrounding the potential nephrotoxic effects of hair-straightening products containing glyoxylic acid. This inquiry was instigated by a patient who experienced three repeated acute episodes of kidney injury in June 2020, April 2021, and July 2022, each occurring shortly after a hair-straightening procedure. Notably, these episodes resolved with hydration.
Upon examining the composition of the hair product used by the patient, which contained glyoxylic acid, and considering the patient's report of painful ulcer scalp during application and subsequent scalp scarring, we suspected a potential link between exposure to glyoxylic acid and kidney injury. Consulting with my colleague, Professor Emmanuel Letavenier, a specialist in crystalline nephropathy at Paris, confirmed this suspicion.
In summer 2023, cases series have been reported by an Israeli team (https://pubmed.ncbi.nlm.nih.gov/36610611/), who described 26 patients presenting with acute renal injuries after hair straightening treatments. Biopsies revealed calcium oxalate crystals in the kidneys. The Israeli researchers suspected an effect of formaldehyde and glycolic acid, another substance found in many cosmetic products, including hair straightening products, but were unable to provide conclusive evidence.
Dr. Thomas Robert[/caption]
MedicalResearch.com Interview with:
Thomas Robert, MD, AIX
Associate Professor of Nephrology
APHM (Assistance Publique - Hopitaux de Marseille)
Marseille, Provence-Alpes-Côte d'Azur, France
[caption id="attachment_61498" align="alignleft" width="132"]
Dr. Letavernier[/caption]
Prof. Emmanuel Letavernier, MD PhD
Nephrologist at Tenon Hospital
Paris, France
MedicalResearch.com: What is the background for this study?
Response: Our work was prompted by emerging concerns surrounding the potential nephrotoxic effects of hair-straightening products containing glyoxylic acid. This inquiry was instigated by a patient who experienced three repeated acute episodes of kidney injury in June 2020, April 2021, and July 2022, each occurring shortly after a hair-straightening procedure. Notably, these episodes resolved with hydration.
Upon examining the composition of the hair product used by the patient, which contained glyoxylic acid, and considering the patient's report of painful ulcer scalp during application and subsequent scalp scarring, we suspected a potential link between exposure to glyoxylic acid and kidney injury. Consulting with my colleague, Professor Emmanuel Letavenier, a specialist in crystalline nephropathy at Paris, confirmed this suspicion.
In summer 2023, cases series have been reported by an Israeli team (https://pubmed.ncbi.nlm.nih.gov/36610611/), who described 26 patients presenting with acute renal injuries after hair straightening treatments. Biopsies revealed calcium oxalate crystals in the kidneys. The Israeli researchers suspected an effect of formaldehyde and glycolic acid, another substance found in many cosmetic products, including hair straightening products, but were unable to provide conclusive evidence.
ADHD, Author Interviews, Dermatology, JAMA, Mental Health Research / 08.03.2024
Hopkins Study Evaluates Risk of Cognitive Impairment in Children with Atopic Dermatitis
MedicalResearch.com Interview with:
[caption id="attachment_61409" align="alignleft" width="125"] Dr. Wan[/caption]
Dr. Joy Wan M.D., M.S.C.E.
Assistant Professor of Dermatology
Johns Hopkins University School of Medicine
MedicalResearch.com: What is the background for this study?
Response: There has been a growing body of literature linking atopic dermatitis with diagnoses such as ADHD and learning disabilities, but studies focusing on symptoms of cognitive impairment (in contrast to relying on reported diagnoses as proxy measures of such) have been fewer and demonstrate inconsistent findings. Thus, we were interested in using data from this nationally representative sample of U.S. children to examine whether atopic dermatitis was associated with symptoms of learning or memory difficulties. Moreover, we wanted to examine how this relationship is influenced by known neurodevelopmental conditions to further characterize whether specific subgroups of children with atopic dermatitis are more susceptible to cognitive impairments.
Dr. Wan[/caption]
Dr. Joy Wan M.D., M.S.C.E.
Assistant Professor of Dermatology
Johns Hopkins University School of Medicine
MedicalResearch.com: What is the background for this study?
Response: There has been a growing body of literature linking atopic dermatitis with diagnoses such as ADHD and learning disabilities, but studies focusing on symptoms of cognitive impairment (in contrast to relying on reported diagnoses as proxy measures of such) have been fewer and demonstrate inconsistent findings. Thus, we were interested in using data from this nationally representative sample of U.S. children to examine whether atopic dermatitis was associated with symptoms of learning or memory difficulties. Moreover, we wanted to examine how this relationship is influenced by known neurodevelopmental conditions to further characterize whether specific subgroups of children with atopic dermatitis are more susceptible to cognitive impairments.
Aging, Author Interviews, Dermatology / 19.02.2024
“Rejuvenation”: Injection of Filler into Photoaged Skin Stimulated Fibroblasts to Produce More Collagen
MedicalResearch.com Interview with:
[caption id="attachment_61338" align="alignleft" width="150"] Dr. Frank Wang[/caption]
Frank Wang MD
William B. Taylor Endowed Professor of Clinical Dermatology
Associate Professor, Dermatology
Associate Chair for Education
Assistant Program Director, Dermatology Residency Program
University of Michigan
Ann Arbor, Michigan
MedicalResearch.com: What is the background for this study? How is the cross-linked hyaluronic acid obtained? Where was it injected?
Response: As the skin undergoes photoaging due to chronic exposure to ultraviolet light, it loses dermal collagen, which in turn leads to wrinkling, lines, and loss of support. The loss of collagen is, in large part, due to reduced function of the skin’s collagen-producing cells, dermal fibroblasts.
We wanted to investigate whether it was possible to reverse the decreased function of fibroblasts in photodamaged skin, by introducing a space-filling material into the dermis, injected CL-HA dermal filler. The CL-HA filler we used was donated to us for research purposes.
We performed injections of CL-HA into the mid-dermis (as is normally done when injected into the face) of severely photoaged forearm skin of human participants over the age of 60. We then examined skin samples at various time points, including 1, 2, 3 and 4 weeks and 3, 6, 9, and 12 months post-injection.
Dr. Frank Wang[/caption]
Frank Wang MD
William B. Taylor Endowed Professor of Clinical Dermatology
Associate Professor, Dermatology
Associate Chair for Education
Assistant Program Director, Dermatology Residency Program
University of Michigan
Ann Arbor, Michigan
MedicalResearch.com: What is the background for this study? How is the cross-linked hyaluronic acid obtained? Where was it injected?
Response: As the skin undergoes photoaging due to chronic exposure to ultraviolet light, it loses dermal collagen, which in turn leads to wrinkling, lines, and loss of support. The loss of collagen is, in large part, due to reduced function of the skin’s collagen-producing cells, dermal fibroblasts.
We wanted to investigate whether it was possible to reverse the decreased function of fibroblasts in photodamaged skin, by introducing a space-filling material into the dermis, injected CL-HA dermal filler. The CL-HA filler we used was donated to us for research purposes.
We performed injections of CL-HA into the mid-dermis (as is normally done when injected into the face) of severely photoaged forearm skin of human participants over the age of 60. We then examined skin samples at various time points, including 1, 2, 3 and 4 weeks and 3, 6, 9, and 12 months post-injection.
Allergies, Author Interviews, Dermatology, University of Michigan / 16.11.2023
Food Allergy: Test Measuring Water Loss Through Skin (TEWL) May Predict Anaphylaxis
MedicalResearch.com Interview with:
[caption id="attachment_61065" align="alignleft" width="150"] Dr. Schuler[/caption]
Charles Schuler, MD
Assistant Professor
Allergy and Clinical Immunology &
Mary H. Weiser Food Allergy Center
University of Michigan
MedicalResearch.com: What is the background for this study?
Response: Anaphylaxis is a severe allergic reaction that may include a skin rash, nausea, vomiting, difficulty breathing, and shock. Food anaphylaxis sends 200,000 people to the emergency room annually in the United States. Oral food challenges are when a patient ingests increasing doses up to a full serving of the suspected food allergen under supervision of a medical provider, usually an allergist. These oral food challenges are the diagnostic standard for food allergy/anaphylaxis as skin and blood allergy tests have high false positive rates. Although a highly accurate test, patients often experience anaphylaxis during oral food challenges necessitating an epinephrine injection.
Dr. Schuler[/caption]
Charles Schuler, MD
Assistant Professor
Allergy and Clinical Immunology &
Mary H. Weiser Food Allergy Center
University of Michigan
MedicalResearch.com: What is the background for this study?
Response: Anaphylaxis is a severe allergic reaction that may include a skin rash, nausea, vomiting, difficulty breathing, and shock. Food anaphylaxis sends 200,000 people to the emergency room annually in the United States. Oral food challenges are when a patient ingests increasing doses up to a full serving of the suspected food allergen under supervision of a medical provider, usually an allergist. These oral food challenges are the diagnostic standard for food allergy/anaphylaxis as skin and blood allergy tests have high false positive rates. Although a highly accurate test, patients often experience anaphylaxis during oral food challenges necessitating an epinephrine injection.
Author Interviews, Dermatology, JAMA, Surgical Research / 16.11.2023
Reduced Recurrence of Pilonidal Cysts with Addition of Laser Hair Removal
MedicalResearch.com Interview with:
[caption id="attachment_61061" align="alignleft" width="142"] Dr. Minneci[/caption]
Peter C. Minneci, MD
Chair of Surgery at Nemours Children’s Health
Delaware Valley
MedicalResearch.com: What is the background for this study? Would you briefly explain the symptoms/course of pilonidal disease?
Response: Pilonidal disease is relatively common and affects up to 1% of the population starting in adolescence and up until young adulthood. Pilonidal disease occurs when cysts or sinuses form between the buttocks. It is believed to be an inflammatory reaction to hair or debris that gets caught in the crease of the buttocks. Risk factors for the condition include a sedentary lifestyle, hygiene and obesity.
[caption id="attachment_61062" align="alignleft" width="150"] Pilonidal Cyst
DermNet Image[/caption] Pilonidal disease can be intermittent or chronic and recurs about 33% of the time, with 80% of recurrences taking place within a year of initial treatment. These recurrences contribute to a high degree of psychosocial stress in patients, who often miss school or sports and may avoid social activities. Pilonidal cysts may become infected, in which case patients must take antibiotics or undergo surgery. Standard treatment for pilonidal disease involves removal of hair with razors or creams, as well as recommendations such as keeping the area clean. In recent years, some practitioners have begun using laser epilation as an additional strategy to prevent recurrence by providing more durable hair removal. However, it’s important to point out that this is not covered by insurance. In addition, as a provider, I have found that my patients that do have the means to pay often don’t comply with the number of sessions needed to fully remove the hair due to many different factors including pain and discomfort during the procedure.
Dr. Minneci[/caption]
Peter C. Minneci, MD
Chair of Surgery at Nemours Children’s Health
Delaware Valley
MedicalResearch.com: What is the background for this study? Would you briefly explain the symptoms/course of pilonidal disease?
Response: Pilonidal disease is relatively common and affects up to 1% of the population starting in adolescence and up until young adulthood. Pilonidal disease occurs when cysts or sinuses form between the buttocks. It is believed to be an inflammatory reaction to hair or debris that gets caught in the crease of the buttocks. Risk factors for the condition include a sedentary lifestyle, hygiene and obesity.
[caption id="attachment_61062" align="alignleft" width="150"]
Pilonidal CystDermNet Image[/caption] Pilonidal disease can be intermittent or chronic and recurs about 33% of the time, with 80% of recurrences taking place within a year of initial treatment. These recurrences contribute to a high degree of psychosocial stress in patients, who often miss school or sports and may avoid social activities. Pilonidal cysts may become infected, in which case patients must take antibiotics or undergo surgery. Standard treatment for pilonidal disease involves removal of hair with razors or creams, as well as recommendations such as keeping the area clean. In recent years, some practitioners have begun using laser epilation as an additional strategy to prevent recurrence by providing more durable hair removal. However, it’s important to point out that this is not covered by insurance. In addition, as a provider, I have found that my patients that do have the means to pay often don’t comply with the number of sessions needed to fully remove the hair due to many different factors including pain and discomfort during the procedure.
Annals Internal Medicine, Author Interviews, Dermatology / 14.11.2023
Acupuncture Studied for Treatment of Chronic Hives
MedicalResearch.com Interview with:
Ying Li MD, PhD
Graduate School
Chengdu University of Traditional Chinese Medicine
Chengdu, China
MedicalResearch.com: What is the background for this study?
Response: Chronic spontaneous urticaria (CSU) is a prevalent dermatological condition affecting approximately 1% of the global population. It is characterized by persistent itching and the development of hives, significantly impairing patients' quality of life. More than 90% of patients with CSU require urgent medical treatment to relieve itching. However, few therapies are specifically designed to treat pruritus in The management of pruritus is one of the main goals in the treatment of chronic spontaneous urticaria .
Antihistamines are a common treatment of CSU, and current guidelines recommend second-generation antihistamines as first-line therapy.
However, nearly 40% of patients do not respond to second-generation antihistamines, even when the dose is increased 2- to 4-fold. Omalizumab as a second-line treatment is effective in controlling urticaria, but it is costly and is not reimbursed in many countries, limiting its use to most patients worldwide. Given the shortcomings of existing therapies for pruritus in CSU, novel therapeutic interventions or strategies are emerging.
Acupuncture, a traditional physical therapy with a rich historical background spanning over a millennium, has been regarded as an effective treatment for urticaria in China. However, previous randomized controlled trials investigating acupuncture's efficacy have been marred by methodological limitations, thereby undermining the credibility of the evidence. To address this gap, we conducted a multicenter randomized controlled trial to comprehensively evaluate the effectiveness of acupuncture in the management of CSU.
Author Interviews, Dermatology, Diabetes, Heart Disease, Weight Research / 28.08.2023
Psoriasis: Case Study Finds Weight Loss Drug Semaglutide Reduced Fat Around Heart
MedicalResearch.com Interview with:
[caption id="attachment_60815" align="alignleft" width="150"] Dr. Malavazos[/caption]
Dr. Alexis Elias Malavazos
Endocrinology Unit
Clinical Nutrition and Cardiovascular Prevention Service,
IRCCS Policlinico
Unit of Radiology, IRCCS Policlinico
San Donato, San Donato Milanese, Italy
MedicalResearch.com: What is the background for this study?
Response: Psoriasis is a systemic inflammatory disease often associated with obesity and type-2 diabetes (T2D). The inflammatory process of psoriasis can target adipose tissue depots, particularly those surrounding the heart and the coronary arteries, exposing them to an increased risk of cardiovascular disease.
Dr. Malavazos[/caption]
Dr. Alexis Elias Malavazos
Endocrinology Unit
Clinical Nutrition and Cardiovascular Prevention Service,
IRCCS Policlinico
Unit of Radiology, IRCCS Policlinico
San Donato, San Donato Milanese, Italy
MedicalResearch.com: What is the background for this study?
Response: Psoriasis is a systemic inflammatory disease often associated with obesity and type-2 diabetes (T2D). The inflammatory process of psoriasis can target adipose tissue depots, particularly those surrounding the heart and the coronary arteries, exposing them to an increased risk of cardiovascular disease.
Author Interviews, Dermatology, Immunotherapy / 18.07.2023
Atopic Dermatitis: Mount Sinai Study Finds Lebrikizumab May Allow Longer Intervals Between Treatments
MedicalResearch.com Interview with:
[caption id="attachment_60633" align="alignleft" width="150"] Dr. Guttman-Yassky[/caption]
Emma Guttman-Yassky, M.D., PhD,
Lead investigator of this study
Waldman Professor and
System Chair
Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai, NY
MedicalResearch.com: What is the background for this study?
Response: The idea to test how spacing out treatment or even stopping it affects treatment responses once patients are well controlled. Lebrikizumab it is a potent biologic agent with a relatively long-lasting effect.
Dr. Guttman-Yassky[/caption]
Emma Guttman-Yassky, M.D., PhD,
Lead investigator of this study
Waldman Professor and
System Chair
Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai, NY
MedicalResearch.com: What is the background for this study?
Response: The idea to test how spacing out treatment or even stopping it affects treatment responses once patients are well controlled. Lebrikizumab it is a potent biologic agent with a relatively long-lasting effect.
Author Interviews, Dermatology, Eli Lilly, Immunotherapy / 18.05.2023
Lilly: Novel Monoclonal Antibody Shows Promise in Hard to Treat Facial and Hand Atopic Dermatitis
MedicalResearch.com Interview with:
[caption id="attachment_60437" align="alignleft" width="200"] Dr. Mallbris[/caption]
Lotus Mallbris, MD PhD
Dermatologist andSenior Vice President
Global Immunology Development and Medical Affairs
Lilly
MedicalResearch.com: What is the background for this study? Would you briefly describe what is meant by atopic dermatitis and types treated in this study?
Response: First, this study specifically evaluated lebrikizumab, a novel, investigational, monoclonal antibody that selectively binds to interleukin 13 (IL-13) with high-affinity and high potency. Inflammation due to over-activation of the IL-13 pathway plays a central role in the pathogenesis of moderate-to-severe atopic dermatitis, commonly called eczema.
This secondary analysis focused on patients treated with lebrikizumab from the 16-week induction periods of the ADvocate 1 and ADvocate 2 studies and the ADhere study. In the trials, we assessed the presence or absence of face or hand dermatitis in patients with moderate-to-severe atopic dermatitis. If present at baseline, at 16 weeks, clinicians assessed the change from baseline on a scale of cleared, improved, no change, or worsened. Only patients with face and hand dermatitis were evaluated as part of the analysis.
Dr. Mallbris[/caption]
Lotus Mallbris, MD PhD
Dermatologist andSenior Vice President
Global Immunology Development and Medical Affairs
Lilly
MedicalResearch.com: What is the background for this study? Would you briefly describe what is meant by atopic dermatitis and types treated in this study?
Response: First, this study specifically evaluated lebrikizumab, a novel, investigational, monoclonal antibody that selectively binds to interleukin 13 (IL-13) with high-affinity and high potency. Inflammation due to over-activation of the IL-13 pathway plays a central role in the pathogenesis of moderate-to-severe atopic dermatitis, commonly called eczema.
This secondary analysis focused on patients treated with lebrikizumab from the 16-week induction periods of the ADvocate 1 and ADvocate 2 studies and the ADhere study. In the trials, we assessed the presence or absence of face or hand dermatitis in patients with moderate-to-severe atopic dermatitis. If present at baseline, at 16 weeks, clinicians assessed the change from baseline on a scale of cleared, improved, no change, or worsened. Only patients with face and hand dermatitis were evaluated as part of the analysis.
Author Interviews, Dermatology, JAMA / 15.05.2023
JAMA Dermatology Study Evaluates Nonsteroidal Roflumilast Foam for Seborrheic Dermatitis
MedicalResearch.com Interview with:
[caption id="attachment_60425" align="alignleft" width="151"] Dr. Zirwas[/caption]
Matthew Zirwas, MD
Founder, Bexley Dermatology Research Clinic
Bexley, OH 43209
MedicalResearch.com: What is the background for this study? How does Roflumilast differ from other treatments for seb derm?
Response: Seborrheic dermatitis affects up to 5% of the population globally and can have major impacts on quality of life. Treatment regimens are often complicated given the association of seborrheic dermatitis to hair bearing areas of the body, requiring multiple treatments for different parts of the body. Our phase 2 study aimed to understand the efficacy and safety of once-daily roflumilast foam 0.3% in adults with seborrheic dermatitis on their scalp, face and trunk. Roflumilast foam is a selective and highly potent phosphodiesterase (PDE) 4 inhibition that is being studied for a range of inflammatory skin conditions.
Dr. Zirwas[/caption]
Matthew Zirwas, MD
Founder, Bexley Dermatology Research Clinic
Bexley, OH 43209
MedicalResearch.com: What is the background for this study? How does Roflumilast differ from other treatments for seb derm?
Response: Seborrheic dermatitis affects up to 5% of the population globally and can have major impacts on quality of life. Treatment regimens are often complicated given the association of seborrheic dermatitis to hair bearing areas of the body, requiring multiple treatments for different parts of the body. Our phase 2 study aimed to understand the efficacy and safety of once-daily roflumilast foam 0.3% in adults with seborrheic dermatitis on their scalp, face and trunk. Roflumilast foam is a selective and highly potent phosphodiesterase (PDE) 4 inhibition that is being studied for a range of inflammatory skin conditions.
Author Interviews, Dermatology, Melanoma, USPSTF / 27.04.2023
USPSTF Issues Skin Cancer Screening Statement
MedicalResearch.com Interview with:
[caption id="attachment_60371" align="alignleft" width="133"] Dr. Ruiz[/caption]
John M. Ruiz, Ph.D
Associate Professor of Clinical Psychology
Department of Psychology
University of Arizona
Dr. Ruiz is the incoming editor-in-chief of the American Psychological Association (APA) journal, Health Psychology
Dr. Ruiz joined the U.S. Preventive Services Task Force in January 2022
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Skin cancer is the most common type of cancer in the United States, but it often does not cause serious complications or death. The Task Force’s recommendation on screening for skin cancer focuses on the effectiveness of visual skin exams for children and adults who do not have any symptoms. When reviewing the latest research, we found that there is currently not enough evidence to tell us whether or not screening people without signs or symptoms is beneficial. This is an I statement.
Dr. Ruiz[/caption]
John M. Ruiz, Ph.D
Associate Professor of Clinical Psychology
Department of Psychology
University of Arizona
Dr. Ruiz is the incoming editor-in-chief of the American Psychological Association (APA) journal, Health Psychology
Dr. Ruiz joined the U.S. Preventive Services Task Force in January 2022
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Skin cancer is the most common type of cancer in the United States, but it often does not cause serious complications or death. The Task Force’s recommendation on screening for skin cancer focuses on the effectiveness of visual skin exams for children and adults who do not have any symptoms. When reviewing the latest research, we found that there is currently not enough evidence to tell us whether or not screening people without signs or symptoms is beneficial. This is an I statement.
Author Interviews, Dermatology, Eli Lilly, NEJM / 26.03.2023
NEJM: Two Phase 3 Trials Find Lebrikizumab Safe and Highly Effective for Atopic Dermatitis
MedicalResearch.com Interview with:
[caption id="attachment_24142" align="alignleft" width="128"] Dr. Jonathan Silverberg[/caption]
Jonathan Silverberg, MD, PHD, MPH
Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Lebrikizumab was previously shown to be safe and effective as a treatment for moderate-severe atopic dermatitis in a phase 2 study. These Phase 3 randomized placebo-controlled trials are the largest studies to date of lebrikizumab in AD. They showed that lebrikizumab was safe and highly effective for the treatment of moderate-severe atopic dermatitis. These studies will hopefully support the approval of lebrikizumab in the United States later this year.
Dr. Jonathan Silverberg[/caption]
Jonathan Silverberg, MD, PHD, MPH
Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Lebrikizumab was previously shown to be safe and effective as a treatment for moderate-severe atopic dermatitis in a phase 2 study. These Phase 3 randomized placebo-controlled trials are the largest studies to date of lebrikizumab in AD. They showed that lebrikizumab was safe and highly effective for the treatment of moderate-severe atopic dermatitis. These studies will hopefully support the approval of lebrikizumab in the United States later this year.
Allergies, Author Interviews, Cancer Research, Dermatology, Melanoma / 17.03.2023
Study Finds Lower Risk of Melanoma in Patients with Atopic History
MedicalResearch.com Interview with:
Jenni Komulainen
University of Eastern Finland | UEF
MedicalResearch.com: What is the background for this study?
Response: The background for this study comes from the earlier findings that the skin cancer risk and atopic status have some connection, but the results have been inconsistent. The connection between atopy and skin cancers may be related to the stimulation of protective immune response or the predisposition to carcinogenesis through chronic inflammation. The aim of this study was to investigate if atopic disorders associate with skin cancers.
Allergies, Author Interviews, Dermatology / 09.03.2023
Eczema: Mount Sinai Study Finds No Increase Risk of Cancer in 5 Year Study of Dupilumab
MedicalResearch.com Interview with:
[caption id="attachment_60156" align="alignleft" width="150"] Dr. Gulati[/caption]
Nicholas Gulati, MD, PhD
Director, Early Detection of Skin Cancer and Oncodermatology Clinic
The Kimberly and Eric J. Waldman
Department of Dermatology
Mount Sinai Health System
New York, New York
MedicalResearch.com: What is the background for this study? What is dupilumab primarily used for?
Response: Dupilumab is a monoclonal antibody that inhibits a specific part of the immune system known as Th2 cells, which are important in the development of various diseases including atopic dermatitis (eczema) and asthma. Therefore, dupilumab has become one of the major treatments for these conditions. Given the increasing use of this drug, it is important to understand the safety of it in terms of cancer development, as that is currently largely unknown.
Dr. Gulati[/caption]
Nicholas Gulati, MD, PhD
Director, Early Detection of Skin Cancer and Oncodermatology Clinic
The Kimberly and Eric J. Waldman
Department of Dermatology
Mount Sinai Health System
New York, New York
MedicalResearch.com: What is the background for this study? What is dupilumab primarily used for?
Response: Dupilumab is a monoclonal antibody that inhibits a specific part of the immune system known as Th2 cells, which are important in the development of various diseases including atopic dermatitis (eczema) and asthma. Therefore, dupilumab has become one of the major treatments for these conditions. Given the increasing use of this drug, it is important to understand the safety of it in terms of cancer development, as that is currently largely unknown.
Author Interviews, Dermatology, JAMA, Pediatrics, Rheumatology / 26.02.2023
Atopic Dermatitis – Eczema: Greater Awareness in Black and Hispanic Children
MedicalResearch.com Interview with: Siri Choragudi Medical Student University of Miami Gil Yosipovitch, MD Professor and Stiefel endowed Chair of Medical Dermatology at the Dr Phillip...
Author Interviews, Cancer Research, Dermatology, Melanoma, Vitamin C / 10.01.2023
Finnish Study Finds Fewer Melanoma Cases Among Regular Users of Vitamin D
MedicalResearch.com Editors' note: Please consult your health care provider before initiating any vitamin supplementation, including Vitamin D as potentially serious side effects are possible.
MedicalResearch.com Interview with:
Prof. Ilkka T Harvima
Department of Dermatology
University of Eastern Finland and Kuopio University Hospital
Kuopio, Finland
MedicalResearch.com: What is the background for this study?
Response: The North Savo Skin Cancer Program in Eastern Finland was launched in 2017, and it aims at reducing the incidence, morbidity and mortality caused by skin cancers, such as basal cell carcinoma, squamous cell carcinoma and melanoma. A part of this program constituted a follow-up project of patients with an assessed risk of skin cancer. There are also several other parts, such as analysis of skin cancer material reposited in the Biobank of Eastern Finland (see the enclosed BMC Cancer 2021 reference), public information, education of general physicians and medical students etc.
In 2021, we published the article in BMC Cancer (enclosed), where we attempted to clarify the reasons for the relatively high melanoma mortality in relation to its incidence in this region (North Savo) of the country. By using the biobank material we also published an article in 2022 showing that melanoma and melanoma in situ associate with keratinocytic premalignant lesions and keratinocyte skin carcinomas (Suhonen V, Siiskonen H, Suni M, Rummukainen J, Mannermaa A, Harvima IT. Malignant and in situ subtypes of melanoma are associated with basal and squamous cell carcinoma and its precancerous lesions. Eur J Dermatol 2022 Apr 1;32(2):187-194. doi: 10.1684/ejd.2022.4221.).
The follow-up study of about 500 subjects is ongoing (COVID-19 caused pretty much trouble for the recruitment). This is focused on finding risk factors and biomarkers for skin cancers and carcinogenesis.
The first study on these follow-up patients was published in 2021 (Komulainen J, Siiskonen H, Harvima IT. Association of elevated serum tryptase with cutaneous photodamage and skin cancers. Int Arch Allergy Immunol 2021;182(11):1135-1142. doi: 10.1159/000517287.).
The article on vitamin D just recently published in Melanoma Research on Dec 28, 2022, is the second one.
The third work in pipeline deals with the association of atopic disorders with skin cancers, and the manuscript is under revision.
So, these provide with some background for the article in Melanoma Research. Actually, we thought that vitamin D use might associate with skin photoaging, actinic keratoses and carcinogenesis, but the only, though very important, finding was its association with melanoma. We have not focused our research just on vitamin D only, but it looks like we need to go further.
Autoimmune skin conditions like Psoriasis can lead to a lifetime of problems. Treatments are one of the many steps professionals...
Author Interviews, Dermatology, Lancet / 13.12.2022
Atopic Dermatitis- Eczema: New Antibody Therapy Has Potential to Modify Disease Course
MedicalResearch.com Interview with:
[caption id="attachment_59823" align="alignleft" width="130"] Dr. Guttman-Yassky[/caption]
Dr. Emma Guttman-Yassky, MD, PhD
Waldman Professor and System Chair
The Kimberly and Eric J. Waldman Department of Dermatology
Director, Center of Excellence in Eczema
Director, Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: The background for this study are studies that show that OX40 is a pathway that is upregulated in patients with atopic dermatitis (or eczema). OX40 is involved in activation of immune molecules associated with allergy and atopy, and also with formation of memory immune cells that are required for disease recurrence. The hypothesis to the study was that giving an OX40 antagonist will not only ameliorate the disease but perhaps have a remittive effect in that the disease will not come back.
Indeed all drug doses were significantly effective at week 16, the primary endpoint compared to placebo and continued to improve towards week 36, the secondary endpoint. In addition, the responders to treatment maintained their responses for an additional 20 weeks, which is unusual, suggesting a potential for disease modification.
Dr. Guttman-Yassky[/caption]
Dr. Emma Guttman-Yassky, MD, PhD
Waldman Professor and System Chair
The Kimberly and Eric J. Waldman Department of Dermatology
Director, Center of Excellence in Eczema
Director, Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: The background for this study are studies that show that OX40 is a pathway that is upregulated in patients with atopic dermatitis (or eczema). OX40 is involved in activation of immune molecules associated with allergy and atopy, and also with formation of memory immune cells that are required for disease recurrence. The hypothesis to the study was that giving an OX40 antagonist will not only ameliorate the disease but perhaps have a remittive effect in that the disease will not come back.
Indeed all drug doses were significantly effective at week 16, the primary endpoint compared to placebo and continued to improve towards week 36, the secondary endpoint. In addition, the responders to treatment maintained their responses for an additional 20 weeks, which is unusual, suggesting a potential for disease modification.